TY  - JOUR

T1  - Impact of in vivo alemtuzumab dose before reduced intensity conditioning and HLA-identical sibling stem cell transplantation: Pharmacokinetics, GVHD, and immune reconstitution

JO  - Blood

PY  - 2010/01/01

AU  - Chakraverty R

AU  - Orti G

AU  - Roughton M

AU  - Shen J

AU  - Fielding A

AU  - Kottaridis P

AU  - Milligan D

AU  - Collin M

AU  - Crawley C

AU  - Johnson P

AU  - Clark A et al

ED  - 

DO  - DOI: 10.1182/blood-2010-05-286856

VL  - 116

IS  - 16

SP  - 3080

EP  - 3088

Y2  - 2024/12/22

ER  -